Correction to: Analysis of autonomic outcomes in APOLLO, a phase III trial of the RNAi therapeutic patisiran in patients with hereditary transthyretin-mediated amyloidosis (Journal of Neurology, (2020), 267, 3, (703-712), 10.1007/s00415-019-09602-8)

Alejandra González-Duarte, John L. Berk, Dianna Quan, Michelle L. Mauermann, Hartmut H. Schmidt, Michael Polydefkis, Márcia Waddington-Cruz, Mitsuharu Ueda, Isabel M. Conceição, Arnt V. Kristen, Teresa Coelho, Cécile A. Cauquil, Céline Tard, Madeline Merkel, Emre Aldinc, Jihong Chen, Marianne T. Sweetser, Jing Jing Wang, David Adams

Research output: Contribution to journal › Comment/debate › peer-review

Fingerprint

Dive into the research topics of 'Correction to: Analysis of autonomic outcomes in APOLLO, a phase III trial of the RNAi therapeutic patisiran in patients with hereditary transthyretin-mediated amyloidosis (Journal of Neurology, (2020), 267, 3, (703-712), 10.1007/s00415-019-09602-8)'. Together they form a unique fingerprint.

Medicine & Life Sciences